EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?

Ahmad Matarneh, Meet Patel, Kinna Parikh, Amanda Karasinski, Gurwant Kaur, Vaqar Shah, Nasrollah Ghahramani iD, Naman Trivedi

Antibodies · 17.06.2025 · 14 (2) · 49

DOI: 10.3390/antib14020049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibodies, online erschienen am 17.06.2025. Verfasst von Ahmad Matarneh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The long-term use of immunosuppressive drugs following kidney transplantation increases the risk of life-threatening infections, malignancies, and, paradoxically, eventual allograft rejection. Therefore, achieving a balance between over-immunosuppression and under-immunosuppression is critical to optimizing patient outcomes. One promising approach is immune cell-based therapy using suppressor immune cells to modulate the immune response more precisely. Among these, regulatory T cells (Tregs) are the most extensively studied and have shown significant potential in the post-transplant setting. Tregs are broadly categorized into thymus-derived and peripherally derived subsets. Physiologically, they play key roles in maintaining immune tolerance, including in autoimmune diseases and within the tumor microenvironment. Their immunosuppressive functions are mediated through both contact-dependent and contact-independent mechanisms. Studies investigating the use of Tregs following kidney transplantation have shown encouraging results. This review summarizes the biology of Tregs and highlights current evidence supporting their role in transplant immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

graft versus host diseaseimmunosuppressive therapykidney transplantregulatory T cellstreg adoptive cell therapy

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA.
  • Department of Internal Medicine, Western Reserve Hospital, Cuyahoga Falls, OH 44223, USA.

ORCID-Profile: Nasrollah Ghahramani

Zitieren

APA

Matarneh, A., Patel, M., Parikh, K., Karasinski, A., Kaur, G., Shah, V., Ghahramani, N., & Trivedi, N. (2025). Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?. Antibodies, 14(2), 49. https://doi.org/10.3390/antib14020049

Vancouver

Matarneh A, Patel M, Parikh K, Karasinski A, Kaur G, Shah V, et al. Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?. Antibodies. 2025;14(2):49. doi:10.3390/antib14020049

BibTeX
@article{Matarneh2025,
  author = {Matarneh, Ahmad and Patel, Meet and Parikh, Kinna and Karasinski, Amanda and Kaur, Gurwant and Shah, Vaqar and Ghahramani, Nasrollah and Trivedi, Naman},
  title = {Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?},
  journal = {Antibodies},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {49},
  doi = {10.3390/antib14020049}
}
Kostenlos starten →